Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

J Guo, X Huang, L Dou, M Yan, T Shen… - Signal Transduction and …, 2022 - nature.com
Aging is a gradual and irreversible pathophysiological process. It presents with declines in
tissue and cell functions and significant increases in the risks of various aging-related …

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics

Y Han, SY Kim - Experimental & Molecular Medicine, 2023 - nature.com
Senescence compromises the essential role that the endothelium plays in maintaining
vascular homeostasis, so promoting endothelial dysfunction and the development of age …

[HTML][HTML] Cellular senescence in cardiovascular diseases: a systematic review

C Hu, X Zhang, T Teng, ZG Ma, QZ Tang - Aging and disease, 2022 - ncbi.nlm.nih.gov
Aging is a prominent risk factor for cardiovascular diseases, which is the leading cause of
death around the world. Recently, cellular senescence has received potential attention as a …

[HTML][HTML] Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid

J Ma, Z Liu, X Gao, Y Bao, Y Hong, X He, W Zhu… - Pharmacological …, 2023 - Elsevier
Accumulating evidence indicates gut microbiota contributes to aging-related disorders.
However, the exact mechanism underlying gut dysbiosis-related pathophysiological …

Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism

Y Gu, QI Zheng, G Fan, R Liu - International Journal of Molecular …, 2022 - mdpi.com
Despite encouraging progresses in the development of novel therapies, cancer remains the
dominant cause of disease-related mortality and has become a leading economic and …

The molecular and cellular basis of Hutchinson–Gilford progeria syndrome and potential treatments

NJ Batista, SG Desai, AM Perez, A Finkelstein… - Genes, 2023 - mdpi.com
Hutchinson–Gilford progeria syndrome (HGPS) is a rare, autosomal-dominant, and fatal
premature aging syndrome. HGPS is most often derived from a de novo point mutation in the …

GLP1 receptor Agonists—effects beyond obesity and diabetes

SS Wilbon, MG Kolonin - Cells, 2023 - mdpi.com
Glucagon-like peptide-1 receptor agonists (GLP1RA) have been transformative for patients
and clinicians in treating type-2 diabetes and obesity. Drugs of this class, the bioavailability …

Vascular senescence in progeria: role of endothelial dysfunction

Q Xu, A Mojiri, L Boulahouache… - … Heart Journal Open, 2022 - academic.oup.com
Abstract Aims Hutchinson–Gilford progeria syndrome (HGPS) is a pre-mature aging disorder
caused by the mutation of the LMNA gene leading to an irreversibly farnesylated lamin A …

[HTML][HTML] Hutchinson-Gilford progeria syndrome: Cellular mechanisms and therapeutic perspectives

B Cisneros, I García-Aguirre, M De Ita… - Archives of Medical …, 2023 - Elsevier
In humans, aging is characterized by a gradual decline of physical and psychological
functions, with the concomitant onset of chronic-degenerative diseases, which ultimately …

A unified model of age-related cardiovascular disease

M Fossel, J Bean, N Khera, MG Kolonin - Biology, 2022 - mdpi.com
Simple Summary Age-related cardiovascular disease is the foremost cause of death
globally. Despite medical advances, we have been unable to stop or reverse the underlying …